ES8303297A1 - Un procedimiento para la preparacion de un nuevo reptido activo. - Google Patents

Un procedimiento para la preparacion de un nuevo reptido activo.

Info

Publication number
ES8303297A1
ES8303297A1 ES507630A ES507630A ES8303297A1 ES 8303297 A1 ES8303297 A1 ES 8303297A1 ES 507630 A ES507630 A ES 507630A ES 507630 A ES507630 A ES 507630A ES 8303297 A1 ES8303297 A1 ES 8303297A1
Authority
ES
Spain
Prior art keywords
preparation
new peptide
pharmaceutically acceptable
compound
pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES507630A
Other languages
English (en)
Spanish (es)
Other versions
ES507630A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES8303297A1 publication Critical patent/ES8303297A1/es
Publication of ES507630A0 publication Critical patent/ES507630A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES507630A 1980-12-01 1981-12-01 Un procedimiento para la preparacion de un nuevo reptido activo. Granted ES507630A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8038509 1980-12-01
GB8102687 1981-01-29
GB8111584 1981-04-13

Publications (2)

Publication Number Publication Date
ES8303297A1 true ES8303297A1 (es) 1983-02-01
ES507630A0 ES507630A0 (es) 1983-02-01

Family

ID=27261059

Family Applications (2)

Application Number Title Priority Date Filing Date
ES507630A Granted ES507630A0 (es) 1980-12-01 1981-12-01 Un procedimiento para la preparacion de un nuevo reptido activo.
ES516390A Granted ES516390A0 (es) 1980-12-01 1982-10-08 Un procedimiento para la preparacion de un nuevo peptido activo.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES516390A Granted ES516390A0 (es) 1980-12-01 1982-10-08 Un procedimiento para la preparacion de un nuevo peptido activo.

Country Status (8)

Country Link
EP (1) EP0053388B1 (h)
AU (1) AU7813681A (h)
CA (1) CA1247083A (h)
DE (1) DE3172076D1 (h)
DK (1) DK521981A (h)
ES (2) ES507630A0 (h)
GR (1) GR81332B (h)
HU (1) HU188110B (h)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565653A (en) * 1984-03-30 1986-01-21 Pfizer Inc. Acyltripeptide immunostimulants
US4619915A (en) * 1984-10-19 1986-10-28 Pfizer Inc. Peptide-substituted heterocyclic immunostimulants
WO1987004440A1 (en) * 1986-01-23 1987-07-30 Pfizer Inc. Heptanoyl-glu-asp-ala-amino acid immunostimulants

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
DE2963446D1 (en) * 1978-11-14 1982-09-16 Fujisawa Pharmaceutical Co New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it
FR2460290A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
EP0027260B1 (en) * 1979-10-11 1985-03-13 Fujisawa Pharmaceutical Co., Ltd. Peptides, processes for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0053388B1 (en) 1985-08-28
ES8400397A1 (es) 1983-11-01
EP0053388A1 (en) 1982-06-09
CA1247083A (en) 1988-12-20
ES516390A0 (es) 1983-11-01
DK521981A (da) 1982-06-02
GR81332B (h) 1984-12-11
ES507630A0 (es) 1983-02-01
DE3172076D1 (en) 1985-10-03
HU188110B (en) 1986-03-28
AU7813681A (en) 1982-06-10

Similar Documents

Publication Publication Date Title
ES8307794A1 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
ES8300112A1 (es) Un procedimiento para preparar compuestos de cefem .
DK0379979T3 (h)
ES8502106A1 (es) Un procedimiento para la preparacion de derivados de diben- zopirano
HUT50345A (en) Process for production of cefem-derivatives and their intermediers
ES8307825A1 (es) "un procedimiento para preparar un compuesto de cefem".
ES8601915A1 (es) Un procedimiento para preparar derivados de piridazinona
EP0033156A3 (en) 1-phenyl-2-cyclohexene-1-alkylamine derivatives, intermediates and process for their preparation, medicines containing them and their use as pharmaceutically active compounds
GB1458251A (en) 1-phenyl-2-amino-ethanol derivatives
YU5893A (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
ES8800235A1 (es) Un procedimiento para preparar un isomero sin de un compues-to de cefem
ES8303297A1 (es) Un procedimiento para la preparacion de un nuevo reptido activo.
ES2000681A6 (es) Un procedimiento para preparar nuevos compuestos de bencilpiperazina
JPS57116098A (en) Novel 3-aminosteroid derivative, salt, manufacture, intermediate, use as drug and composition containing same
ES8304924A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama.
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
ES8304923A1 (es) Un procedimiento para la preparacion de un peptido.
ES8304925A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido &-glutamil-diaminopimelilo.
JPS5225772A (en) Preparation of molecular compound of allantoin and ornithine
ES8305307A1 (es) Un procedimiento para la preparacion de un aciltripeptido.
IE812421L (en) Peptides
PT83141A (en) Process for the preparation of 3,7-disubstituted-3-cephem compounds useful as antimicrobial agents
JPS51136886A (en) New biologica lly active substance, ml-236c, and its preparation
ES8407478A1 (es) Un procedimiento para la preparacion de nuevos derivados de tetrahidroquinolina.
JPS5219647A (en) Preparation of 3-aminomethyl-4- homoisotwistane and its acid addition salt